Anticancer phototherapy using activation of E -combretastatins by two-photon–induced isomerization
- 27 October 2014
- journal article
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 20 (5) , 051004
Abstract
The photoisomerization of relatively nontoxic -combretastatins to clinically active -isomers is shown to occur in solution through both one- and two-photon excitations at 340 and 625 nm, respectively. The photoisomerization is also demonstrated to induce mammalian cell death by a two-photon absorption process at 625 nm. Unlike conventional photodynamic therapy (PDT), the mechanism of photoisomerization is oxygen-independent and active in hypoxic environments such as in tumors. The use of red or near-infrared (NIR) light for two-photon excitation allows greater tissue penetration than conventional UV one-photon excitation. The results provide a baseline for the development of a novel phototherapy that overcomes nondiscriminative systemic toxicity of -combretastatins and the limitations of PDT drugs that require the presence of oxygen to promote their activity, with the added benefits of two-photon red or NIR excitation for deeper tissue penetration.
Keywords
This publication has 18 references indexed in Scilit:
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerBritish Journal of Cancer, 2010
- Kinetics of reversible photoisomerization: determination of the primary quantum yields for the E-Z photoisomerization of silylenephenylenevinylene derivativesPhotochemical & Photobiological Sciences, 2009
- Antivascular Actions of Microtubule-Binding DrugsClinical Cancer Research, 2009
- New Two-Photon Activated Photodynamic Therapy Sensitizers Induce Xenograft Tumor Regressions after Near-IR Laser Treatment through the Body of the Host MouseClinical Cancer Research, 2008
- Blood-vessel closure using photosensitizers engineered for two-photon excitationNature Photonics, 2008
- Phase I Trial of Combretastatin A-4 Phosphate with CarboplatinClinical Cancer Research, 2005
- Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?Organic & Biomolecular Chemistry, 2003
- In vivooptical characterization of human tissues from 610 to 1010 nm by time-resolved reflectance spectroscopyPhysics in Medicine & Biology, 2001
- Cis‐TransPhotoisomerization of Stilbenes and Stilbene‐Like Molecules1994
- Photochromic heterocyclic fulgides. Part 2. Electrocyclic reactions of (E)-α-2,5-dimethyl-3-furylethylidene(alkyl-substituted methylene)succinic anhydridesJournal of the Chemical Society, Perkin Transactions 1, 1981